JSM 2011 Online Program

The views expressed here are those of the individual authors and not necessarily those of the JSM sponsors, their officers, or their staff.

Activity Details


228 Mon, 8/1/2011, 2:00 PM - 3:50 PM CC-A205
The Use of Historical Data Priors in the Design and Analysis of Clinical Trials — Topic Contributed Papers
Biopharmaceutical Section , Section on Health Policy Statistics
Organizer(s): David Ohlssen, Novartis
Chair(s): David Ohlssen, Novartis
2:05 PM Evaluating Probability of Study Success Through Bayesian Evidence Haoda Fu, Eli Lilly and Company
2:25 PM A Bayesian Adaptive Dose Selection Procedure with a Count Endpoint Luca Pozzi, University of California at Berkeley ; Heinz Schmidli, Novartis Pharma AG ; Mauro Gasparini, Politecnico di Torino ; Amy Racine, Novartis
2:45 PM From Historical Data to Priors Beat Neuenschwander, Novartis Pharma AG
3:05 PM Examples of Safety and Efficacy Analyses in Early Clinical Development Incorporating Historical Data Neal Thomas, Pfizer Inc.
3:25 PM Discussant: Ram C. Tiwari, U.S. Food and Drug Administration/CDER/OTS/OB
3:45 PM Floor Discussion



2011 JSM Online Program Home

For information, contact jsm@amstat.org or phone (888) 231-3473.

If you have questions about the Continuing Education program, please contact the Education Department.